rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Balaxi Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Income
Operating income 101.29 86.87 45.63 13.60 -
Expenses
Material consumed 76.92 63.33 33.58 10.24 -
Manufacturing expenses - - - - -
Personnel expenses 2.90 1.95 1.76 0.90 0.15
Selling expenses 0.40 0.07 0.10 0.02 0.03
Adminstrative expenses 3.81 2.63 3.73 0.81 0.59
Expenses capitalised - - - - -
Cost of sales 84.03 67.98 39.17 11.96 0.77
Operating profit 17.26 18.89 6.46 1.63 -0.77
Other recurring income 2.75 1.81 2.81 0.81 -
Adjusted PBDIT 20.01 20.70 9.27 2.44 -0.77
Financial expenses 0.06 0.01 - - -
Depreciation 0.25 0.09 0.01 - -
Other write offs - - - - -
Adjusted PBT 19.70 20.60 9.27 2.44 -0.77
Tax charges 5.03 5.46 2.77 0.47 -
Adjusted PAT 14.67 15.13 6.50 1.97 -
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 14.67 15.13 6.50 1.97 -0.77
Earnigs before appropriation 36.61 21.95 6.81 0.32 -1.65
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 36.61 21.95 6.81 0.32 -1.65

Mutual Fund Selector

Find the fund that is right for you
Close
Add Balaxi Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Balaxi Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close